共 10 条
[2]
Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients[J] . Akihiko Yoshizawa,Shinji Sumiyoshi,Makoto Sonobe,Masashi Kobayashi,Masakazu Fujimoto,Fumi Kawakami,Tatsuaki Tsuruyama,William D. Travis,Hiroshi Date,Hironori Haga.Journal of Thoracic Oncology . 2013 (1)
[4]
Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy[J] . Adi F. Gazdar.Cancer and Metastasis Reviews . 2010 (1)
[5]
Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway[J] . Kim-Son H. Nguyen,Susumu Kobayashi,Daniel B. Costa.Clinical Lung Cancer . 2009 (4)
[7]
ErbBs in lung cancer[J] . Sreenath V. Sharma,Jeffrey Settleman.Experimental Cell Research . 2008 (4)
[8]
Correlation between morphology and EGFR mutations in lung adenocarcinomas[J] . Hironori Ninomiya,Miyako Hiramatsu,Kentaro Inamura,Kimie Nomura,Michiyo Okui,Tatsu Miyoshi,Sakae Okumura,Yukitoshi Satoh,Ken Nakagawa,Makoto Nishio,Takeshi Horai,Satoshi Miyata,Eiju Tsuchiya,Masashi Fukayama,Yuichi Ishikawa.Lung Cancer . 2008 (2)
[9]
Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis[J] . Noriko Motoi,Janos Szoke,Gregory J. Riely,Venkatraman E. Seshan,Mark G. Kris,Valerie W. Rusch,William L. Gerald,William D. Travis.The American Journal of Surgical Pathology . 2008 (6)